First Heartland Consultants’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $518K | Buy |
|
|||||
|
2025
Q1 | $458K | Sell |
|
|||||
|
2024
Q4 | $503K | Buy |
|
|||||
|
2024
Q3 | $456K | Sell |
|
|||||
|
2024
Q2 | $376 | Buy |
|
|||||
|
2024
Q1 | $294K | Buy |
|
|||||
|
2023
Q4 | $415K | Buy |
|
|||||
|
2023
Q3 | $285K | Buy |
|
|||||
|
2023
Q2 | $291K | Sell |
|
|||||
|
2023
Q1 | $606K | Sell |
|
|||||
|
2022
Q4 | $632K | Sell |
|
|||||
|
2022
Q3 | $486 | Sell |
|
|||||
|
2022
Q2 | $559K | Buy |
|
|||||
|
2022
Q1 | $463K | Buy |
|
|||||
|
2021
Q4 | $526 | Sell |
|
|||||
|
2021
Q3 | $528K | Buy |
|
|||||
|
2021
Q2 | $442K | Buy |
|
|||||
|
2021
Q1 | $292K | Buy |
|
|||||
|
2020
Q4 | $227K | Sell |
|
|||||
|
2020
Q3 | $252K | Buy |
|
|||||
|
2020
Q2 | $270K | Sell |
|
|||||
|
2020
Q1 | $279K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $230K | Sell |
|
|||||
|
2017
Q4 | $218K | Sell |
|
|||||
|
2017
Q3 | $723K | Hold |
|
|||||
|
2017
Q2 | $632K | Buy |
|
|||||
|
2017
Q1 | $604K | Sell |
|
|||||
|
2016
Q4 | $988K | Sell |
|
|||||
|
2016
Q3 | $1.55M | Buy |
|
|||||
|
2016
Q2 | $1.23K | Sell |
|
|||||
|
2016
Q1 | $2.54M | Sell |
|
|||||
|
2015
Q4 | $3M | Sell |
|
|||||
|
2015
Q3 | $3.96M | Sell |
|
|||||
|
2015
Q2 | $4.83K | Sell |
|
|||||
|
2015
Q1 | $4.26M | Buy |
|
|||||
|
2014
Q4 | $2.55M | Buy |
|
|||||
|
2014
Q3 | $863K | Buy |
|